review_id,review_id_label,m_design,m_countr,vaccine,vaccine_other,dose_delay_min,dose_delay_interval,vac_l,vac_u,study_l,study_u,num_vaccinated,sample_size,num_controls,age_inc_min,age_inc_max,age_case_min,age_case_max,age_cases_mean,age_cases_median,age_cases_IQR,age_cases_sdev,vaccination_status_acser,case_ascertainment,case_inclusion_criteria,dehydration,symptomatic,control_ascertainement,control_inclusion_criteria,case_confirmation,case_confirmation_other,non_case_confirmation,non_case_confirmation_other,estim_unadj,estim_unadj_ci_l,estim_unadj_ci_u,estim_unadj_se,estim_adj,estim_adj_ci_l,estim_adj_ci_u,estim_adj_se,n_cases_vaccinated,n_noncases_vaccinated,n_cases_unvaccinated,n_noncases_unvaccinated,main_estimate,doses_l,doses_u,serotype_majority,serotype_majority_description,serotype_minority,serotype_minority_description,biotype_majority,biotype_majority_description,biotype_minority,biotype_minority_description,f_source,m_design_comment,m_countr_comment,vaccine_comment,vaccine_other_comment,dose_delay_comment,vac_l_comment,vac_u_comment,study_l_comment,study_u_comment,num_vaccinated_comment,sample_size_comment,num_controls_comment,age_inc_min_comment,age_inc_max_comment,age_case_min_comment,age_case_max_comment,age_cases_mean_comment,age_cases_median_comment,age_cases_IQR_comment,vaccination_status_acser_comment,case_ascertainment_comment,case_inclusion_criteria_comment,dehydration_coomment,symptomatic_comment,control_ascertainement_comment,control_inclusion_criteria_comment,case_confirmation_comment,case_confirmation_other_comment,non_case_confirmation_comment,non_case_confirmation_other_comment,estim_unadj_comment,estim_unadj_ci_l_comment,estim_unadj_ci_u_comment,estim_unadj_se_comment,estim_adj_comment,estim_adj_ci_l_comment,estim_adj_ci_u_comment,estim_adj_se_comment,n_cases_vaccinated_comment,n_noncases_vaccinated_comment,n_cases_unvaccinated_comment,n_noncases_unvaccinated_comment,doses_l_comment,doses_u_comment,cholera_serotype_comment,cholera_biotype_comment,f_source_comment,general_comment
2810,"Azman et al, 2016",5,SDN,1,,,,2015-07-31,2015-09-01,2015-08-09,2015-09-29,375,932,557,1,Inf,2,48,23.1,25,17-29,,2,1,"individuals aged 1 year and older on the first day of the vaccination campaign who sought care for diarrhoea at participating health structures; who had three or more loose stools in the preceding 24 h; who had lived in the same residence during the preceding 2 weeks (within a 2 h drive of central Juba); and who had not visited a health facility for diarrhoea before Aug 1, 2015, but reported that they would do so for severe diarrhoea.",,,2,Eligible cases were those aged 1 year and older on the fi rst day of the vaccination campaign who sought care for diarrhoea at all three cholera treatment centres and seven rehydration posts throughout Juba. Confirmed cases were suspected cases who tested positive to PCR for Vibrio cholerae O1.,4,,"2,3,4, and 5","5 refers to ""Suspecte cases ... and who had not visited a health facility for diarrhoea before Aug 1, 2015, but reported that they would do so for severe diarrhoea.""",80.2,61.5,100,,87.3,70.2,100,,2,373,32,525,1,1,1,1,,,,,,,,Medecines sans frontieres,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2011-07-26,33127,69328,36201,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,62,49,72,,60,46,71,,82,33045,234,35967,,1,2,2,95%Ogawa,1,,1,100%,,,"Bill & Melinda Gates Foundation and the governments of South Korea, Sweden and Kuwait",,,,,,,,1 days after receipt of first dose,1825 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2011-07-26,2166,4542,2376,1,4.9,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,43,10,63,,39,4,61,,31,2135,59,2317,,1,2,2,95%Ogawa,1,,1,100%,,,Bill & Melinda Gates Foundation and the governments of South Korea and Sweden.,,,,,,,,1 days after receipt of first dose,1825 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2011-07-26,7237,15130,7893,5,14.9,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,65,38,80,,65,39,80,,21,7216,65,7828,,1,2,2,95%Ogawa,1,,1,100%,,,Bill & Melinda Gates Foundation and the governments of South Korea and Sweden.,,,,,,,,1 days after receipt of first dose,1825 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2011-07-26,23724,49656,25932,15,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,70,54,81,,69,53,80,,30,23694,110,25822,,1,2,2,95%Ogawa,1,,1,100%,,,Bill & Melinda Gates Foundation and the governments of South Korea and Sweden.,,,,,,,,1 days after receipt of first dose,1825 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2007-07-27,33127,69328,36201,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,42,-6,68,,40,-10,67,,18,33109,34,36167,,1,2,2,95%Ogawa,1,,1,100%,,,Bill & Melinda Gates Foundation and the governments of South Korea and Sweden.,,,,,,,,1 days after receipt of first dose,365 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2007-07-28,2008-07-26,31714,66417,34703,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,76,50,89,,72,42,87,,10,31704,46,34657,,1,2,2,95%Ogawa,1,,1,100%,,,Bill & Melinda Gates Foundation and the governments of South Korea and Sweden.,,,,,,,,366 days after receipt of first dose,730 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2008-07-27,2009-07-26,30065,62849,32784,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,60,31,77,,57,26,75,,21,30044,57,32727,,1,2,2,95%Ogawa,1,,1,100%,,,Bill & Melinda Gates Foundation and the governments of South Korea and Sweden.,,,,,,,,731 days after receipt of first dose,1095 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2009-07-27,2010-07-26,28664,59902,31238,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,57,27,75,,60,33,76,,29,28635,74,31164,,1,2,2,95%Ogawa,1,,1,100%,,,Bill & Melinda Gates Foundation and the governments of South Korea and Sweden.,,,,,,,,1097 days after receipt of first dose,1460 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
210,"Bhattacharya et al, 2013",1,IND,1,,14,30,2006-07-27,2006-09-10,2010-07-27,2011-07-26,27148,56715,29567,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,81,44,93,,81,42,94,,4,27144,23,29544,,1,2,2,95%Ogawa,1,,1,100%,,,Bill & Melinda Gates Foundation and the governments of South Korea and Sweden.,,,,,,,,1461 days after receipt of first dose,1825 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,BS-WC ,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,21141,42361,21220,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,85,62,94,,,,,,4,21137,26,21194,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,"The trial used ""conventional technique"". We need to read the cited article to determine what the techniques are.",,,,,,,,,,,,,,,,"How do we characterize the exact dose??_""vaccinated""=a subject must have received three doses of the assigned agent in different rounds, and completely ingested the first dose, and ingested at least three-quarters of the second and third doses",,,,,
1584,"Clemens et al, 1986",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,21137,42357,21220,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,58,14,79,,,,,,11,21126,26,21194,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,BS-WC ,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,8825,17761,8936,2,10,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,92,,,,,,,,1,8824,13,8923,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,BS-WC ,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,12316,24600,12284,10.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,77,,,,,,,,3,12313,13,12271,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 10-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,BS-WC ,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,21141,42361,21220,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.","1,2",,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,89,,,,,,,,2,21139,18,21202,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,BS-WC ,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,21141,42361,21220,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",3,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,75,,,,,,,,2,21139,8,21212,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,BS-WC ,42,,1985-01-01,1985-05-31,1985-04-09,1985-06-17,21141,42361,21220,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,87,,,,,,,,2,21139,15,21205,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,83 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,BS-WC ,42,,1985-01-01,1985-05-31,1985-06-18,1985-09-18,20986,42057,21071,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,82,,,,,,,,2,20984,11,21060,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,84 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,8838,17774,8936,2,10,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,53,,,,,,,,6,8832,13,8923,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 10-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,12299,24583,12284,10.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,62,,,,,,,,5,12294,13,12271,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,21137,42357,21220,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.","1,2",,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,44,,,,,,,,10,21127,18,21202,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-18,21137,42357,21220,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",3,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,87,,,,,,,,1,21136,8,21212,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-06-17,21137,42357,21220,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,60,,,,,,,,6,21131,15,21205,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,83 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1584,"Clemens et al, 1986",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-06-18,1986-02-15,20974,42045,21071,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,54,,,,,,,,5,20969,11,21060,,3,3,2,,1,,1,,2,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,84 days after 3rd dose,176 days after 3rd dose,,,,From children aged 2-15 years and women aged over 15 years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1551,"Clemens et al, 1988",1,BGD,5,BS-WC ,42,,1985-01-01,1985-05-31,1985-04-09,1985-06-17,20705,41542,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,62,47,,,,,,,41,20705,110,20727,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,83 days after receipt 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-06-17,20743,41580,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,53,34,,,,,,,52,20753,110,20727,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,83 days after receipt 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-07-25,20705,41542,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,79,,,,,,,,4,20701,19,20818,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,121 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-07-26,1985-11-24,20515,41169,20654,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,62,,,,,,,,11,20504,29,20625,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,122 days after 3rd dose,243 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-11-25,1986-03-26,20304,40714,20410,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,58,,,,,,,,26,20278,62,20348,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,244 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-31,20705,41542,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,85,,,,,,,,4,20701,26,20811,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1985-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-02-31,20439,41002,20563,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,52,,,,,,,,26,20413,54,20509,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-10-01,1986-02-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1986-03-01,1986-05-31,20156,40357,20201,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,63,,,,,,,,11,20145,30,20171,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1986-03-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-07-25,20743,41580,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,52,,,,,,,,9,20734,19,20818,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,121 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-07-26,1985-11-24,20558,41212,20654,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,34,,,,,,,,19,20539,29,20625,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,122 days after 3rd dose,243 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-11-25,1986-03-26,20333,40743,20410,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,61,,,,,,,,24,20309,62,20348,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,244 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-31,20743,41580,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,58,,,,,,,,11,20732,26,20811,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1985-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-02-31,20483,41046,20563,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,39,,,,,,,,33,20450,54,20509,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-10-01,1986-02-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1986-03-01,1986-05-31,20158,40359,20201,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,73,,,,,,,,8,20150,30,20171,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1986-03-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,20705,41542,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.","1,2",,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,61,,,,,,,,24,20681,62,20775,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,20705,41542,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",3,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,64,,,,,,,,17,20688,48,20789,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,20743,41580,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.","1,2",,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,50,,,,,,,,31,20712,62,20775,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,20743,41580,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",3,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,56,,,,,,,,21,20722,48,20789,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,3728,7558,3830,2,5.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,38,,,,,,,,26,3702,43,3787,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,9061,18150,9089,6,15.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,83,,,,,,,,6,9055,36,9053,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,7916,15834,7918,16,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,71,,,,,,,,9,7907,31,7887,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,3900,7730,3830,2,5.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,31,,,,,,,,30,3870,43,3787,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,9049,18138,9089,6,15.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,69,,,,,,,,11,9038,36,9053,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,7794,15712,7918,16,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,64,,,,,,,,11,7783,31,7887,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-31,807,1652,845,2,2.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,85,,,,,,,,2,805,14,831,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-10-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-01,1986-05-31,814,1673,859,2,2.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,85,,,,,,,,2,812,14,845,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-31,2914,5885,2971,3,5.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,100,,,,,,,,0,2914,9,2962,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1985-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-01,1986-05-31,2914,5885,2971,3,5.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,16,,,,,,,,24,2890,29,2942,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-31,16977,33984,17007,6,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,76,,,,,,,,4,16973,17,16990,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1985-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-31,16750,33542,16792,6,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,78,,,,,,,,11,16739,50,16742,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-10-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-01,1986-05-31,16977,33984,17007,6,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,78,,,,,,,,15,16962,67,16940,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-31,886,1731,845,2,2.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,66,,,,,,,,5,881,14,831,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-10-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-01,1986-05-31,903,1762,859,2,2.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,59,,,,,,,,6,897,14,845,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-31,2997,5968,2971,3,5.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,45,,,,,,,,5,2992,9,2962,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1985-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-31,2957,5883,2926,3,5.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,6,,,,,,,,19,2938,20,2906,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-10-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-01,1986-05-31,2997,5968,2971,3,5.92,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,18,,,,,,,,24,2973,29,2942,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-31,16843,33850,17007,6,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,70,,,,,,,,5,16838,17,16990,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1985-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-31,16640,33432,16792,6,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,66,,,,,,,,17,16623,50,16742,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-10-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1551,"Clemens et al, 1988",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-01,1986-05-31,16843,33850,17007,6,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,67,,,,,,,,22,16821,67,16940,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,1985-04-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,From children aged 2-15 years and women aged over 15 years
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1988-08-22,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,50,39,One tail,,,,,,131,,266,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1988-08-22,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,52,41,One tail,,,,,,127,,266,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-08-23,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,38,7,One tail,,,,,,26,,43,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-08-23,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,78,66,One tail,,,,,,15,,67,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-08-23,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,62,50,One tail,,,,,,41,,110,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-08-23,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,47,13,One tail,,,,,,16,,31,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-08-23,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,61,44,One tail,,,,,,26,,67,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-08-23,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,57,42,One tail,,,,,,42,,98,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-08-22,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-37,-129,One tail,,,,,,24,,18,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-08-22,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,40,9,One tail,,,,,,24,,40,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-08-22,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,17,-15,One tail,,,,,,48,,58,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-08-23,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,31,-1,One tail,,,,,,30,,43,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-08-23,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,67,51,One tail,,,,,,22,,67,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-08-23,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,53,38,One tail,,,,,,52,,110,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-08-23,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,24,-19,One tail,,,,,,24,,31,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-08-23,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,73,59,One tail,,,,,,18,,67,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-08-23,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,57,42,One tail,,,,,,42,,98,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-08-22,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,2,-70,One tail,,,,,,18,,18,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-08-22,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,62,39,One tail,,,,,,15,,40,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-08-22,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,43,19,One tail,,,,,,33,,58,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,26,4,One tail,,,,,,66,,92,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 1st dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,63,53,One tail,,,,,,65,,174,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 1st dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,23,1,One tail,,,,,,72,,92,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 1st dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,68,59,One tail,,,,,,55,,174,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 1st dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,12,-29,One tail,,,,,,36,,41,,,1,1,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 1st dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-02-26,1988-07-11,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,64,45,One tail,,,,,,18,,50,,,2,2,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 2nd dose,1095 days after 2nd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,24,-12,One tail,,,,,,31,,41,,,1,1,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 1st dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-02-26,1988-07-11,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,39,12,One tail,,,,,,31,,50,,,2,2,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 2nd dose,1095 days after 2nd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1988-08-22,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,50,39,One tail,,,,,,131,,266,,1,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1988-08-22,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,52,41,One tail,,,,,,127,,266,,1,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",3,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,46,28,One tail,,,,,,48,,89,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 1st dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.","1,2",,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,53,42,One tail,,,,,,83,,177,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 2nd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",3,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,50,33,One tail,,,,,,44,,89,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 1st dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1493,"Clemens et al, 1990",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-01-15,1988-05-30,,,,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.","1,2",,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,53,42,One tail,,,,,,83,,177,,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,,,,14 days after 1st dose,1095 days after 2nd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,1097,2159,1062,2,Inf,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,57,21,One tail,,,,,,11,1086,24,1038,,3,3,,,,,,,,,,,,,,,,,Given in the paper. Estimate off by a month from our estimate in OCV1287. 14 days after the start of the 3rd vacci round,Given in the paper. Estimate off by a month from our estimate in OCV1287. 365 days after the final third dose was given,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,1097,2159,1062,2,Inf,,,,,,,1,1,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,74,30,One tail,,,,,,3,1094,11,1051,,3,3,,,,,,,,,,,,,,,,,Given in the paper. Estimate off by a month from our estimate in OCV1287. 14 days after the start of the 3rd vacci round,Given in the paper. Estimate off by a month from our estimate in OCV1287. 365 days after the final third dose was given,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,1097,2159,1062,2,Inf,,,,,,,1,2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,42,-20,One tail,,,,,,8,1089,13,1049,,3,3,,,,,,,,,,,,,,,,,Given in the paper. Estimate off by a month from our estimate in OCV1287. 14 days after the start of the 3rd vacci round,Given in the paper. Estimate off by a month from our estimate in OCV1287. 365 days after the final third dose was given,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,1126,2188,1062,2,Inf,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,58,23,One tail,,,,,,11,1115,24,1038,,3,3,,,,,,,,,,,,,,,,,Given in the paper. Estimate off by a month from our estimate in OCV1287. 14 days after the start of the 3rd vacci round,Given in the paper. Estimate off by a month from our estimate in OCV1287. 365 days after the final third dose was given,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,1126,2188,1062,2,Inf,,,,,,,1,1,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,50,-14,One tail,,,,,,6,1120,11,1051,,3,3,,,,,,,,,,,,,,,,,Given in the paper. Estimate off by a month from our estimate in OCV1287. 14 days after the start of the 3rd vacci round,Given in the paper. Estimate off by a month from our estimate in OCV1287. 365 days after the final third dose was given,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,1126,2188,1062,2,Inf,,,,,,,1,2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,65,19,One tail,,,,,,5,1121,13,1049,,3,3,,,,,,,,,,,,,,,,,Given in the paper. Estimate off by a month from our estimate in OCV1287. 14 days after the start of the 3rd vacci round,Given in the paper. Estimate off by a month from our estimate in OCV1287. 365 days after the final third dose was given,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,193,406,213,2,5.9,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,59,-21,One tail,,,,,,3,190,8,205,,3,3,,,,,,,,,,,,,,,,,Given in the paper. Estimate off by a month from our estimate in OCV1287. 14 days after the start of the 3rd vacci round,Given in the paper. Estimate off by a month from our estimate in OCV1287. 365 days after the final third dose was given,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,904,1753,849,6,Inf,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,54,8,One tail,,,,,,8,896,16,833,,3,3,,,,,,,,,,,,,,,,,Given in the paper. Estimate off by a month from our estimate in OCV1287. 14 days after the start of the 3rd vacci round,Given in the paper. Estimate off by a month from our estimate in OCV1287. 365 days after the final third dose was given,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-30,262,499,237,2,5.9,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,81,39,One tail,,,,,,2,260,9,228,,3,3,,,,,,,,,,,,,,,,,1985-04-01,1985-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-21,835,1660,825,6,Inf,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,42,-16,One tail,,,,,,9,826,15,810,,3,3,,,,,,,,,,,,,,,,,1985-10-01,1986-05-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,193,406,213,2,Inf,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,20,-90,One tail,,,,,,7,186,8,205,,3,3,,,,,,,,,,,,,,,,,1985-04-21,1986-05-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,904,1753,849,2,Inf,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,77,46,One tail,,,,,,4,900,16,833,,3,3,,,,,,,,,,,,,,,,,1985-04-21,1986-05-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-30,262,499,237,2,Inf,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,63,4,One tail,,,,,,4,258,9,228,,3,3,,,,,,,,,,,,,,,,,1985-04-01,1985-09-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-21,835,1660,825,2,Inf,,,,,,,1,1 and 2,Cholera infection was defined as fecal excretion of V. cholera Ol and was termed symptomatic if such excretion occurred from 48 h before onset to 48 h after the end of a diarrheal episode.,,,,,3,,,,56,7,One tail,,,,,,7,828,15,810,,3,3,,,,,,,,,,,,,,,,,1985-10-01,1986-05-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"*has data for the entire study, but no breakdown for any VE estimate ",,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,1097,2159,1062,2,Inf,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,46,15,One tail,,,,,,20,1077,35,1027,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,1126,2188,1062,2,Inf,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,32,-5,One tail,,,,,,26,1100,35,1027,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,193,406,213,2,5.9,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,-8,,One tail,,,,,,4,189,4,209,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,904,1753,849,6,Inf,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,53,22,One tail,,,,,,16,888,31,818,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-30,262,499,237,2,Inf,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,39,-22,One tail,,,,,,10,252,14,223,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-21,835,1660,825,2,Inf,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,54,14,One tail,,,,,,10,825,21,804,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,193,406,213,2,5.9,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,-83,,One tail,,,,,,8,185,4,209,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-21,1986-05-21,904,1753,849,6,Inf,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,46,13,One tail,,,,,,18,886,31,818,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-01,1985-09-30,262,499,237,2,Inf,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,70,33,One tail,,,,,,5,257,14,223,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
1416,"Clemens et al, 1992",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-05-21,835,1660,825,2,Inf,,,,,,,1,1 and 2,Other cholera infections were classified as asymptomatic; the onset of asymptomatic infection was taken as the first day in which excretion of V. cholerae 01 was detected.,,1,,,3,,,,5,-59,One tail,,,,,,21,814,21,804,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,This paper has also biotype VE estimations
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2014-03-09,45417,235,188,1,Inf,,,28.5,25.1,12.2-41.8,20.9,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,63,39,88,,63,8,85,,33,167,14,21,,1,2,2,77%,1,23%,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2014-03-09,4087.53,57,40,1,Inf,,,,,,,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,80,13,95,,67,-62,93,,3,19,14,21,,1,1,,,,,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2014-03-09,41329.47,213,169,1,Inf,,,,,,,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,72,37,87,,62,6,85,,30,148,14,21,1,2,2,2,,1,,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2014-03-09,45417,235,188,1,Inf,,,28.5,25.1,12.2-41.8,20.9,1 or 2,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,65,28,83,,58,13,80,,27,147,20,41,,1,2,2,77%,1,23%,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2014-03-09,,40,31,1,4.9,,,,,,,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,50,-850,97,,,,,,,,,,,1,2,,,,,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,Study_l and study_u are not specific to subanalysis,Study_l and study_u are not specific to subanalysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2014-03-09,,195,157,5,Inf,,,,,,,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,72,36,88,,,,,,,,,,,1,2,,,,,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,Study_l and study_u are not specific to subanalysis,Study_l and study_u are not specific to subanalysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2014-03-09,,,,1,Inf,,,,,,,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",2,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,72,3,92,,,,,,,,,,,1,2,,,,,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,Study_l and study_u are not specific to subanalysis,Study_l and study_u are not specific to subanalysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2014-03-09,,,,1,Inf,,,,,,,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",1,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,73,23,91,,,,,,,,,,,1,2,,,,,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,Study_l and study_u are not specific to subanalysis,Study_l and study_u are not specific to subanalysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2012-10-24,2013-06-30,,61,49,1,Inf,,,,,,,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,87,32,98,,,,,,,,,,,1,2,,,,,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,<1 yr since vaccination,<1 yr since vaccination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
110,"Ivers et al, 2015",2,HTI,1,,,,2012-04-01,2012-06-01,2013-07-01,2014-03-09,,174,139,1,Inf,,,,,,,3,1,"individuals with acute watery diarrhoea—defined as three or more loose, non-bloody, liquid stools in a 24-h period with an onset of 3 days or fewer before presentation—who sought treatment at any of the three study sites and met all eligibility criteria.",,,2,"Controls were matched by age group,residency and enrollment time. Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.",2 and 3,,5,Controls were individuals who did not seek treatment for diarrhoea between the first day of study enrolment and the date of onset of symptoms in their corresponding case.,64,10,86,,,,,,,,,,,1,2,,,,,,,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,,,>1 yr since vaccination,>1 yr since vaccination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
288,"Khatib et al, 2012",3,TZA,2,,12,23,2009-01-11,2009-01-26,2009-09-14,2010-04-12,23921,44421,20500,2,Inf,,,24.8,24.2,14.2-36.2,14,1,1,"All healthy, non-pregnant residents aged 2 years and older. A cholera episode is defined as acute non-bloody diarrhoea in a patient presenting for treatment whose faecal specimen yielded V cholerae O1.",,,2,"A cholera episode is defined as acute non-bloody diarrhoea in a patient presenting for treatment whose faecal specimen yielded V cholerae O1. All healthy, non-pregnant residents aged 2 years and older are eligible for the study.",3,,1,,79,47,92,,,,,,6,23915,33,20467,1,2,2,2,100%,,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, and the South Korean Government.",,,,,,,,Cholera cases were detected in the study area starting from 7 to 14 months after the end of the vaccination campaign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
288,"Khatib et al, 2012",3,TZA,2,,12,23,2009-01-11,2009-02-16,2009-09-14,2010-04-12,3757,24257,20500,2,Inf,,,,,,,1,1,"All healthy, non-pregnant residents aged 2 years and older. A cholera episode is defined as acute non-bloody diarrhoea in a patient presenting for treatment whose faecal specimen yielded V cholerae O1.",,,2,"A cholera episode is defined as acute non-bloody diarrhoea in a patient presenting for treatment whose faecal specimen yielded V cholerae O1. All healthy, non-pregnant residents aged 2 years and older are eligible for the study.",3,,1,,46,-80,83,,,,,,3,3754,33,20467,,1,1,2,100%,,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, and the South Korean Government.",,,,,,,,Cholera cases were detected in the study area starting from 7 to 14 months after the end of the vaccination campaign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
799,"Lucas et al, 2005",2,MOZ,2,,25,,2003-12-11,2004-01-12,2004-01-12,2004-05-26,,45,36,2,4.9,,,,,,,1 or 2,1,"People with acute, nonbloody diarrhea severe enough to cause them to seek care at the Cholera Treatment Center between January 1 and May 31, 2004, were eligible if they gave written informed consent, had resided in study area since Dec 11, 2013, were at least 2 years of age, were not pregnant during the time of mass vaccination, were positive for V.cholerae O1, and their residence can be located after discharge for acquisition of information about vaccination and other data.",,,2,"Controls are neighbors matched by sex, age group and had not sought treatment for diarrhea at the Cholera Treatment Center between Dec 11 2003, and the onset of the matched case's diarrheal illness but would if severe, watery diarrhea had developed.",3,,1,,82,-19,98,,,,,,2,22,7,14,,1,2,2,100%,,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first round of immunization was conducted from December 11 to 20, 2003, and the second round from January 5 to 12, 2004, thus ensuring a minimum of 15 days between doses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
799,"Lucas et al, 2005",2,MOZ,2,,25,,2003-12-11,2004-01-12,2004-01-12,2004-05-26,,,,15,Inf,,,,,,,1 or 2,1,"People with acute, nonbloody diarrhea severe enough to cause them to seek care at the Cholera Treatment Center between January 1 and May 31, 2004, were eligible if they gave written informed consent, had resided in study area since Dec 11, 2013, were at least 2 years of age, were not pregnant during the time of mass vaccination, were positive for V.cholerae O1, and their residence can be located after discharge for acquisition of information about vaccination and other data.",,,2,"Controls are neighbors matched by sex, age group and had not sought treatment for diarrhea at the Cholera Treatment Center between Dec 11 2003, and the onset of the matched case's diarrheal illness but would if severe, watery diarrhea had developed.",3,,1,,72,24,91,,,,,,,,,,,1,2,2,100%,,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first round of immunization was conducted from December 11 to 20, 2003, and the second round from January 5 to 12, 2004, thus ensuring a minimum of 15 days between doses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
799,"Lucas et al, 2005",2,MOZ,2,,25,,2003-12-11,2004-01-12,2004-01-12,2004-05-26,,170,136,5,Inf,,,,,,,1 or 2,1,"People with acute, nonbloody diarrhea severe enough to cause them to seek care at the Cholera Treatment Center between January 1 and May 31, 2004, were eligible if they gave written informed consent, had resided in study area since Dec 11, 2013, were at least 2 years of age, were not pregnant during the time of mass vaccination, were positive for V.cholerae O1, and their residence can be located after discharge for acquisition of information about vaccination and other data.",,,2,"Controls are neighbors matched by sex, age group and had not sought treatment for diarrhea at the Cholera Treatment Center between Dec 11 2003, and the onset of the matched case's diarrheal illness but would if severe, watery diarrhea had developed.",3,,1,,67,16,86,,,,,,8,72,26,64,,1,2,2,100%,,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first round of immunization was conducted from December 11 to 20, 2003, and the second round from January 5 to 12, 2004, thus ensuring a minimum of 15 days between doses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
799,"Lucas et al, 2005",2,MOZ,2,,25,,2003-12-11,2004-01-12,2004-01-12,2004-05-26,,50,40,2,Inf,,,,,,,1 or 2,1,"People with acute, nonbloody diarrhea severe enough to cause them to seek care at the Cholera Treatment Center between January 1 and May 31, 2004, were eligible if they gave written informed consent, had resided in study area since Dec 11, 2013, were at least 2 years of age, were not pregnant during the time of mass vaccination, were positive for V.cholerae O1, and their residence can be located after discharge for acquisition of information about vaccination and other data.",1,,2,"Controls are neighbors matched by sex, age group and had not sought treatment for diarrhea at the Cholera Treatment Center between Dec 11 2003, and the onset of the matched case's diarrheal illness but would if severe, watery diarrhea had developed.",3,,1,,89,7,99,,,,,,2,24,8,16,,1,2,2,100%,,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first round of immunization was conducted from December 11 to 20, 2003, and the second round from January 5 to 12, 2004, thus ensuring a minimum of 15 days between doses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
799,"Lucas et al, 2005",2,MOZ,2,,25,,2003-12-11,2004-01-12,2004-01-12,2004-05-26,,165,132,2,Inf,,,,,,,1 or 2,1,"People with acute, nonbloody diarrhea severe enough to cause them to seek care at the Cholera Treatment Center between January 1 and May 31, 2004, were eligible if they gave written informed consent, had resided in study area since Dec 11, 2013, were at least 2 years of age, were not pregnant during the time of mass vaccination, were positive for V.cholerae O1, and their residence can be located after discharge for acquisition of information about vaccination and other data.",2,,2,"Controls are neighbors matched by sex, age group and had not sought treatment for diarrhea at the Cholera Treatment Center between Dec 11 2003, and the onset of the matched case's diarrheal illness but would if severe, watery diarrhea had developed.",3,,1,,,,,,73,33,91,,8,70,25,62,,1,2,2,100%,,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first round of immunization was conducted from December 11 to 20, 2003, and the second round from January 5 to 12, 2004, thus ensuring a minimum of 15 days between doses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
799,"Lucas et al, 2005",2,MOZ,2,,25,,2003-12-11,2004-01-12,2004-01-12,2004-05-26,14164,215,172,2,Inf,,,19,,,13,1 or 2,1,"People with acute, nonbloody diarrhea severe enough to cause them to seek care at the Cholera Treatment Center between January 1 and May 31, 2004, were eligible if they gave written informed consent, had resided in study area since Dec 11, 2013, were at least 2 years of age, were not pregnant during the time of mass vaccination, were positive for V.cholerae O1, and their residence can be located after discharge for acquisition of information about vaccination and other data.",,,2,"Controls are neighbors matched by sex, age group and had not sought treatment for diarrhea at the Cholera Treatment Center between Dec 11 2003, and the onset of the matched case's diarrheal illness but would if severe, watery diarrhea had developed.",3,,1,,,,,,78,39,92,,10,94,33,78,,1,2,2,100%,,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first round of immunization was conducted from December 11 to 20, 2003, and the second round from January 5 to 12, 2004, thus ensuring a minimum of 15 days between doses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Intention to treat,,,,,,,,,,,,,
799,"Lucas et al, 2005",2,MOZ,2,,25,,2003-12-11,2004-01-12,2004-01-12,2004-05-26,11070,195,156,2,Inf,,,,,,,1 or 2,1,"People with acute, nonbloody diarrhea severe enough to cause them to seek care at the Cholera Treatment Center between January 1 and May 31, 2004, were eligible if they gave written informed consent, had resided in study area since Dec 11, 2013, were at least 2 years of age, were not pregnant during the time of mass vaccination, were positive for V.cholerae O1, and their residence can be located after discharge for acquisition of information about vaccination and other data.",,,2,"Controls are neighbors matched by sex, age group and had not sought treatment for diarrhea at the Cholera Treatment Center between Dec 11 2003, and the onset of the matched case's diarrheal illness but would if severe, watery diarrhea had developed.",3,,1,,,,,,84,43,95,,8,80,31,76,1,2,2,2,100%,,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first round of immunization was conducted from December 11 to 20, 2003, and the second round from January 5 to 12, 2004, thus ensuring a minimum of 15 days between doses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,per protocol,,,,,,,,,,,,,
155,"Luquero et al, 2014",2,GIN,1,,14,,2012-04-18,2012-06-16,2012-06-08,2012-10-19,,41,27,1.1,Inf,,,,,,,3,1,"All patients with suspected cholera (acute, nonbloody, watery diarrhea with more than 3 liquid stools in 24 hours)  who were seeking care in a health center in the study area between 1 week after the end of the vaccination campaigns and Oct 31,2012, provided written informed consents, and fulfilled the following criteria: they had resided in the study area since April16, 2012; they were 12months and older; they had a positive esult of rapid diagnostic test for cholera; and their residence could be located after discharge. Persons with repeated episodes of watery diarrhea during the study periods were included in the study only for the first episode.",,,2,"Controls were matched by sex, age group and residency, and was eligible if he or she had not sought treatment for diarrhea between Jan 1, 2012 and the date of onset of the matched case patient's diarheal illness and if he or she would have sought treatment in ahealth center if sevre, watery diarrhea had developed.","3,4",,1,,66.2,-53,92.6,,,,,,6,17,8,10,,1,1,2,100%,,,1,100%,,,Medecines sans Frontieres,,,,,,4/18/2006 in Boffa;2006-05-27 in Forecariah,5/14/2006 in Boffa; 2006-06-15 in Forecariah,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,*vaccinatoin was considered incomplete if .....or one or both doses were spat out or vomited,*vaccinatoin was considered incomplete if .....or one or both doses were spat out or vomited,,,,
155,"Luquero et al, 2014",2,GIN,1,,14,,2012-04-18,2012-06-16,2012-06-08,2012-10-19,,67,55,1.1,Inf,,,,,,,3,1,"All patients with suspected cholera (acute, nonbloody, watery diarrhea with more than 3 liquid stools in 24 hours)  who were seeking care in a health center in the study area between 1 week after the end of the vaccination campaigns and Oct 31,2012, provided written informed consents, and fulfilled the following criteria: they had resided in the study area since April16, 2012; they were 12months and older; they had a positive esult of rapid diagnostic test for cholera; and their residence could be located after discharge. Persons with repeated episodes of watery diarrhea during the study periods were included in the study only for the first episode.",,,2,"Controls were matched by sex, age group and residency, and was eligible if he or she had not sought treatment for diarrhea between Jan 1, 2012 and the date of onset of the matched case patient's diarheal illness and if he or she would have sought treatment in ahealth center if sevre, watery diarrhea had developed.","3,4",,1,,91.6,58.6,98.3,,,,,,4,45,8,10,,2,2,2,100%,,,1,100%,,,"National Institutes of Health, Delivering Oral Vaccines Eff ectively project, and Department of Global Health and Social Medicine at Harvard Medical School.",,,,,,4/18/2006 in Boffa;2006-05-27 in Forecariah,5/14/2006 in Boffa; 2006-06-15 in Forecariah,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
155,"Luquero et al, 2014",2,GIN,1,,14,,2012-04-18,2012-06-16,2012-06-08,2012-10-19,,88,59,1.1,Inf,,,28,28,18-36,16.7,3,1,"All patients with suspected cholera (acute, nonbloody, watery diarrhea with more than 3 liquid stools in 24 hours)  who were seeking care in a health center in the study area between 1 week after the end of the vaccination campaigns and Oct 31,2012, provided written informed consents, and fulfilled the following criteria: they had resided in the study area since April16, 2012; they were 12months and older; they had a positive esult of rapid diagnostic test for cholera; and their residence could be located after discharge. Persons with repeated episodes of watery diarrhea during the study periods were included in the study only for the first episode.",,,2,"Controls were matched by sex, age group and residency, and was eligible if he or she had not sought treatment for diarrhea between Jan 1, 2012 and the date of onset of the matched case patient's diarheal illness and if he or she would have sought treatment in ahealth center if sevre, watery diarrhea had developed.",2,,1,,38.9,-55.2,76,,42.8,-83.6,82.2,,14,36,15,23,,1,1,2,100%,,,1,100%,,,Medecines sans Frontieres,,,,,,4/18/2006 in Boffa;2006-05-27 in Forecariah,5/14/2006 in Boffa; 2006-06-15 in Forecariah,,,,,,,,,,,doesn't have vac-status specific age.,18-36 *but it's does not have dose specific age. This is for all cases.,,,,,,,,,,,,,,,,,,,,,,,,*vaccinatoin was considered incomplete if .....or one or both doses were spat out or vomited,*vaccinatoin was considered incomplete if .....or one or both doses were spat out or vomited,,,,
155,"Luquero et al, 2014",2,GIN,1,,14,,2012-04-18,2012-06-16,2012-06-08,2012-10-19,,150,124,1.1,Inf,,,28,28,18-36,16.7,3,1,"All patients with suspected cholera (acute, nonbloody, watery diarrhea with more than 3 liquid stools in 24 hours)  who were seeking care in a health center in the study area between 1 week after the end of the vaccination campaigns and Oct 31,2012, provided written informed consents, and fulfilled the following criteria: they had resided in the study area since April16, 2012; they were 12months and older; they had a positive esult of rapid diagnostic test for cholera; and their residence could be located after discharge. Persons with repeated episodes of watery diarrhea during the study periods were included in the study only for the first episode.",,,2,"Controls were matched by sex, age group and residency, and was eligible if he or she had not sought treatment for diarrhea between Jan 1, 2012 and the date of onset of the matched case patient's diarheal illness and if he or she would have sought treatment in ahealth center if sevre, watery diarrhea had developed.",2,,1,,84,59.7,93.6,,86.6,56.7,95.8,,11,101,15,23,1,2,2,2,100%,,,1,100%,,,Medecines sans Frontieres,,,,,,4/18/2006 in Boffa;2006-05-27 in Forecariah,5/14/2006 in Boffa; 2006-06-15 in Forecariah,,,,,,,,,,,doesn't have vac-status specific age.,18-36 *but it's does not have dose specific age. This is for all cases.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2013-03-02,94675,174731,80056,1,Inf,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,42,17,60,,37,13,55,,65,94610,106,79950,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first dose was given between Feb 17, and April 16, 2011, and the second dose was given between March 15, and April 16, 2011.",,,"Followup period, not first or last day of cholera cases. // 14 days after the second dose for two-dose recipient.","Followup period, not first or last day of cholera cases..716 days after the start of follow-up",,,,,,,,,,,,,,,,,,,,,,overall effectiveness,,,,,,,,,,,,,,,,,overall effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2013-03-02,9440,17521,8081,1,4.9,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,57,4,81,,52,-4,78,,8,9432,18,8063,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first dose was given between Feb 17, and April 16, 2011, and the second dose was given between March 15, and April 16, 2011.",,,"Followup period, not first or last day of cholera cases. // 14 days after the second dose for two-dose recipient.","Followup period, not first or last day of cholera cases..716 days after the start of follow-up",,,,,,,,,,,,,,,,,,,,,,overall effectiveness,,,,,,,,,,,,,,,,,overall effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2013-03-02,19393,36081,16688,5,14.9,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,52,-49,85,,33,-88,76,,6,19387,12,16676,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first dose was given between Feb 17, and April 16, 2011, and the second dose was given between March 15, and April 16, 2011.",,,"Followup period, not first or last day of cholera cases. // 14 days after the second dose for two-dose recipient.","Followup period, not first or last day of cholera cases..716 days after the start of follow-up",,,,,,,,,,,,,,,,,,,,,,overall effectiveness,,,,,,,,,,,,,,,,,overall effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2013-03-02,65842,121129,55287,15,Inf,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,37,11,56,,34,6,53,,51,65791,76,55211,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first dose was given between Feb 17, and April 16, 2011, and the second dose was given between March 15, and April 16, 2011.",,,"Followup period, not first or last day of cholera cases. // 14 days after the second dose for two-dose recipient.","Followup period, not first or last day of cholera cases..716 days after the start of follow-up",,,,,,,,,,,,,,,,,,,,,,overall effectiveness,,,,,,,,,,,,,,,,,overall effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2012-03-16,94675,174731,80056,1,Inf,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,39,-4,64,,31,-15,58,,41,94634,62,79994,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first dose was given between Feb 17, and April 16, 2011, and the second dose was given between March 15, and April 16, 2011.",,,"Followup period, not first or last day of cholera cases. // 14 days after the second dose for two-dose recipient.","Followup period, not first or last day of cholera cases..716 days after the start of follow-up",,,,,,,,,,,,,,,,,,,,,,overall effectiveness,,,,,,,,,,,,,,,,,overall effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2012-03-17,2013-03-02,53170,104542,51372,1,Inf,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,48,9,70,,45,9,67,,24,53146,44,51328,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,"The first dose was given between Feb 17, and April 16, 2011, and the second dose was given between March 15, and April 16, 2011.",,,"Followup period, not first or last day of cholera cases. // 14 days after the second dose for two-dose recipient.","Followup period, not first or last day of cholera cases..716 days after the start of follow-up",,,,,,,,,,,,,,,,,,,,,,overall effectiveness,,,,,,,,,,,,,,,,,overall effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2013-03-02,61970,140488,78518,1,Inf,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,57,32,72,,53,29,68,,34,61936,105,78413,1,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,total effectiveness,,,,,,,,,,,,,,,,,total effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2013-03-02,6271,12814,6543,1,4.9,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,54,-14,82,,44,-35,77,,7,6264,17,6526,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,total effectiveness,,,,,,,,,,,,,,,,,total effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2013-03-02,15335,32023,16688,5,14.9,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,52,-61,86,,33,-94,77,,5,15330,12,16676,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,total effectiveness,,,,,,,,,,,,,,,,,total effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2013-03-02,40364,95651,55287,15,Inf,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,58,33,73,,56,31,72,,22,40342,76,55211,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,total effectiveness,,,,,,,,,,,,,,,,,total effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2011-03-17,2012-03-16,61970,140488,78518,1,Inf,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,53,15,75,,49,10,71,,21,61949,61,78457,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,total effectiveness,,,,,,,,,,,,,,,,,total effectiveness
75,"Qadri et al, 2015",1,BGD,1,,14,13,2011-02-17,2011-04-16,2012-03-17,2013-03-02,37083,87481,50398,1,Inf,,,,,,,"1,2",1,"A cholera episode was defined as a diarrhoeal episode with no passage of bloody stools, if a faecal specimen yielded V cholerae O1 or O139 and a follow-up check at home, done within 7 days of discharge, confi rmed that the participant had visited the treatment centre for diarrhoea on the recorded date of presentation.",,,,Non-pregnant residents aged 1 year and older in Dhaka Bangladesh,3,,,,61,21,80,,60,23,79,,13,37070,44,50354,,2,2,2,"2 ""only 6 out of 528 were inaba""",,,1,100%,,,Bill and Melinda Gates Foundation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,total effectiveness,,,,,,,,,,,,,,,,,total effectiveness
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-07-09,102552,204700,102148,1,Inf,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation.",,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,40,10,60,,40,11,60,,38,102514,63,102085,1,1,1,2,99%,1,1%,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-07-09,10221,19986,9765,1,4.9,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation.",,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,16,-50,52,,16,-49,53,,22,10199,25,9740,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-07-09,25705,50958,25253,5,14.9,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation.",,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,63,-39,90,,63,-39,90,,3,25702,8,25245,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-07-09,66626,133756,67130,15,Inf,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation.",,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,56,16,77,,56,16,77,,13,66613,30,67100,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-04-10,102552,204700,102148,1,Inf,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation.",,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,34,-25,65,,33,-25,65,,16,102536,24,102124,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-04-11,2014-07-09,83931,167646,83715,1,Inf,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation.",,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,44,5.1,67,,44,6.2,67,,22,83909,39,83676,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-07-09,102552,204700,102148,1,Inf,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation. Severe dehyration is defined as episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria",1,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,63,24,82,,63,24,82,,10,102542,27,102121,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,7 days after dosing,180 days after dosing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"These estimates are for severly dehidrating cholera (episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria) Article also provides estimates for cholera (nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139)"
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-07-09,10221,19986,9765,1,4.9,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation. Severe dehyration is defined as episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria",1,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,28,-222,84,,28,-221,84,,3,10218,4,9761,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,7 days after dosing,180 days after dosing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"These estimates are for severly dehidrating cholera (episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria) Article also provides estimates for cholera (nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139)"
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-07-09,25705,50958,25253,5,14.9,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation. Severe dehyration is defined as episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria",1,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,84,36,98,,84,-36,98,,1,25704,6,25247,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,7 days after dosing,180 days after dosing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"These estimates are for severly dehidrating cholera (episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria) Article also provides estimates for cholera (nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139)"
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-07-09,66626,133756,67130,15,Inf,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation. Severe dehyration is defined as episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria",1,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,64,9.8,86,,64,10,86,,6,66620,17,67113,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,7 days after dosing,180 days after dosing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"These estimates are for severly dehidrating cholera (episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria) Article also provides estimates for cholera (nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139)"
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-01-17,2014-04-10,102552,204700,102148,1,Inf,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation. Severe dehyration is defined as episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria",1,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,72,-37,94,,72,-37,94,,2,102550,7,102141,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,7 days after dosing,90 days after dosing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"These estimates are for severly dehidrating cholera (episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria) Article also provides estimates for cholera (nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139)"
14,"Qadri et al, 2016",1,BGD,1,,,,2014-01-10,2014-02-04,2014-04-11,2014-07-09,83944,167674,83730,1,Inf,,,,,,,"1,2",1,"nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139 and in which a postdischarge visit to the patient’s home confirmed that the person whose name had been given at the treatment center had indeed sought care for diarrhea on the date of presentation. Severe dehyration is defined as episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria",1,,,Nonpregnant residents in Mirpur Dhaka who were 1 year of age or older.,3,,,,60,9.4,82,,60,10,82,,8,83936,20,83710,,1,1,2,,,,1,100%,,,Bill and Melinda Gates Foundation and others,,,,,,,,91 days after dosing,180 days after dosing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"These estimates are for severly dehidrating cholera (episode of culture-confirmed cholera in which severe dehydration, ascertained according to the WHO criteria) Article also provides estimates for cholera (nonbloody diarrhea, with onset at least 7 days after the day on which the vaccine or placebo was received, in which a fecal culture yielded V. cholerae O1 or O139)"
1344,"Sanchez et al, 1994",1,PER,5,"SBL, WC-BS",7,10.5,1994-01-01,1994-03-31,1994-01-04,1994-06-15,710,1426,716,17,65,,,,,,,1,1,"17-65 years old, have been at the military training centre for at least 3 months. non-bloody diarrhoea (three or more loose stools in a 24 h period) with onset 2 or more weeks after the second dose, associated with the isolation of V cholerae 01 1 from a faecal sample.",,,,"17-65 years old, have been at the military training centre for at least 3 months, and to give  written informed consent",3,,,,42,-96,83,,,,,,4,706,7,709,,2,2,2,100,,,1,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptomless infection,,,,,,,,,,,,,,,,,
1344,"Sanchez et al, 1994",1,PER,5,"SBL, WC-BS",7,10.5,1994-01-01,1994-03-31,1994-01-04,1994-06-15,710,1426,716,17,65,,,,,,,1,1,"17-65 years old, have been at the military training centre for at least 3 months. symptomless, associated with the isolation of V cholerae 01 from a faecal sample.",,,,"17-65 years old, have been at the military training centre for at least 3 months, and to give  written informed consent",3,,,,86,37,97,,,,,,2,708,14,702,1,2,2,2,,,,1,100,,,,,,,,,,,"Conflicted information presented..Article also said ""cases started to occur 2-3 weeks after the second dose was given (late Jan 1994).",,,,,,,,,,,,,,,,,,,,,,,symptomatic infection,,,,,,,,,,,,,,El Tor Ogawa was isolated from 54 subjects and Inaba from 4. (but these include cases not eligible for the study),,,
479,"Sur et al, 2009",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2008-07-26,33127,69328,36201,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,62,44,,,62,42,one-tailed,,28,33099,80,36121,,1,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,730 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
479,"Sur et al, 2009",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2008-07-26,2166,4542,2376,1,4.9,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,41,0,,,40,-3,one-tailed,,14,2152,26,2350,,1,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,730 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
479,"Sur et al, 2009",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2008-07-26,7237,15130,7893,5,14.9,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,84,56,,,83,54,one-tailed,,3,7234,21,7872,,1,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,730 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
479,"Sur et al, 2009",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2008-07-26,23724,49656,25932,15,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,64,33,,,61,28,one-tailed,,11,23713,33,25899,,1,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,730 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
479,"Sur et al, 2009",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2007-07-27,33127,69328,36201,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,,,,,40,-1,one-tailed,,18,33109,34,36167,,1,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,365 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
479,"Sur et al, 2009",1,IND,1,,14,30,2006-07-27,2006-09-10,2007-07-27,2008-07-26,31674,66321,34647,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,,,,,72,49,one-tailed,,10,31664,46,34601,,1,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,366 days after receipt of first dose,730 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,intention to treat,,,,,,,,,,,,,
335,"Sur et al, 2011",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2009-07-26,33127,69329,36202,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,,,,,61,47,one-tailed,,49,33078,137,36065,,2,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,1095 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,per protocol,,,,,,,,,,,,,
335,"Sur et al, 2011",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2009-07-26,2082,4345,2263,1,4.9,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,,,,,43,7,one-tailed,,16,2066,32,2231,,2,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,1095 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,per protocol,,,,,,,,,,,,,
335,"Sur et al, 2011",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2009-07-26,7023,14721,7698,5,14.9,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,,,,,88,71,one-tailed,,4,7019,41,7657,,2,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,1095 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,per protocol,,,,,,,,,,,,,
335,"Sur et al, 2011",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2009-07-26,22827,47834,25007,15,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,,,,,61,37,one-tailed,,18,22809,55,24952,,2,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,1095 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,per protocol,,,,,,,,,,,,,
335,"Sur et al, 2011",1,IND,1,,14,30,2006-07-27,2006-09-10,2006-07-28,2009-07-26,31932,66900,34968,1,Inf,,,,,,,1,1,"Non-pregnant individuals older than 1 year residing in Kolkata. A diarrhoeal visit was defined as having, in the 24 h before presentation, at least three loose stools or (if one, two, or an indeterminate number of loose stools were reported) the patient must have shown evidence of some or severe dehydration according to WHO criteria. The primary endpoint, an episode of cholera for which a patient sought care at a health-care facility, was defined as a diarrhoeal episode in which no component visit was described as bloody, in which a fecal specimen yielded V cholerae O1, and the visit to treatment centre is confirmed",,,,"Kolkata residents who are aged 1 year or older, were not pregnant, and provided written consent",3,,,,,,,,66,53,one-tailed,,38,31894,128,34840,1,2,2,2,,1,,1,100%,,,"Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, Governments of South Korea, Sweden, and Kuwait.",,,,,,,,1 days after receipt of first dose,1095 days after receipt of first dose,,,,,,,,,,,,,,,,,,,,,,,,,,per protocol,,,,,,,,,,,,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-01-30,1994-01-01,1994-12-31,9012,17799,8787,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,-3.6,-88,43,,,,,,17,8995,16,8771,,2,2,2,97%,1,3.03%,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1995-01-01,1995-12-31,7594,14997,7403,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,60.5,28,79,,,,,,13,7581,32,7371,,3,3,2,91%,,9%,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1994-01-01,1994-12-31,10592,20992,10400,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,1.7,-65,41,,,,,,22,10570,22,10378,,1,2,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,intent to treat,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1995-01-01,1995-12-31,9020,17887,8867,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,50.9,19,70,,,,,,20,9000,40,8827,,1,3,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,intent to treat,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-01-30,1994-01-01,1994-12-31,1198,2368,1170,2,5,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,-288.9,-2550,43,,,,,,4,1194,1,1169,,2,2,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-01-30,1994-01-01,1994-12-31,3436,6782,3346,6,15,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,30.3,-92,75,,,,,,5,3431,7,3339,,2,2,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-01-30,1994-01-01,1994-12-31,4378,8649,4271,16,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,2.4,-129,58,,,,,,8,4370,8,4263,,2,2,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1995-01-01,1995-12-31,1040,2040,1000,2,5,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,51.5,-140,90,,,,,,2,1038,4,996,,3,3,2,,,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1995-01-01,1995-12-31,3056,6049,2993,6,15,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,46.4,-38,79,,,,,,6,3050,11,2982,,3,3,2,,,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1995-01-01,1995-12-31,3498,6908,3410,16,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,71.7,28,89,,,,,,5,3493,17,3393,,3,3,2,,,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-01-30,1994-01-01,1994-12-31,9012,17799,8787,2,Inf,,,,,,,1,1,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,-30,-383,65,,,,,,4,9008,3,8784,,2,2,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1995-01-01,1995-12-31,7594,14997,7403,2,Inf,,,,,,,1,1,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,82.3,27,96,,,,,,2,7592,11,7392,1,3,3,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-01-30,1994-01-01,1994-12-31,9012,17799,8787,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,1 or 2,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,34.9,-97,79,,,,,,4,9008,6,8781,,2,2,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-01-30,1994-01-01,1994-12-31,9012,17799,8787,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,3,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,-8.4,-139,51,,,,,,10,9002,9,8778,,2,2,2,,1,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1995-01-01,1995-12-31,7594,14997,7403,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,1 or 2,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,57.3,17,78,,,,,,11,7583,25,7378,,3,3,2,,,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1995-01-01,1995-12-31,7594,14997,7403,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,3,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,61.1,-83,92,,,,,,2,7592,5,7398,,3,3,2,,,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1089,"Taylor et al, 2000",1,PER,5,"SBL, WC-rBS",10,19,1993-11-01,1994-11-30,1994-01-01,1995-12-31,12044,23898,11854,2,65,,,,,,,1,1 and 2,An episode of cholera was defined as diarrhea plus the isolation of V.cholerae O1 from the stool during the pisode or within 3 days before or after the episode.,,,,Residents in the vaccine trial area who are 2-65 years old were eligible.,3,,,,28.3,-2,50,,,,,,51,11993,70,11784,,1,3,2,,,,1,100,,,"US Army Medical Materiel and Development Command, Fort Detrick, Maryland.",,,,,"14 (10-28) between the first two doses, 10 month between the 2nd and 3rd dose",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"""more than 90% of the cases were caused by ElTor Ogawa.""",,,
1257,"Trach et al, 1997",1,VNM,5,WC,14,,1992-12-01,1993-01-01,1993-08-20,1993-10-04,51975,119033,67058,1,Inf,,,,,,,1,1,admitted to a polyclinic or hospital with diarrhoea and if a faecal sample obtained during the admission yielded V cholerae O1.,,,,Hue residents at least 1 years old. Controls were same age enumerated in the census and residing in an odd-numbered household.,3,,,,65,45,78,,66,46,79,,25,51950,92,66966,1,2,2,2,100%,,,1,100%,,,"Ministry of Health of Vietnam, the Swedish Agency for Research Cooperation with Developing Countries, the Global Program on Vaccines and Immunisation of the WHO, and the USA National Institute of Child Health and Human Development.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1257,"Trach et al, 1997",1,VNM,5,WC,14,,1992-12-01,1993-01-01,1993-08-20,1993-10-04,67395,134453,67058,1,Inf,,,,,,,1,1,admitted to a polyclinic or hospital with diarrhoea and if a faecal sample obtained during the admission yielded V cholerae O1.,,,,Hue residents at least 1 years old. Controls were same age enumerated in the census and residing in an odd-numbered household.,3,,,,60,40,73,,,,,,37,67358,92,66966,,1,2,2,100%,,,1,100%,,,"Ministry of Health of Vietnam, the Swedish Agency for Research Cooperation with Developing Countries, the Global Program on Vaccines and Immunisation of the WHO, and the USA National Institute of Child Health and Human Development.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1257,"Trach et al, 1997",1,VNM,5,WC,14,,1992-12-01,1993-01-01,1993-08-20,1993-10-04,7192,14249,7057,1,5,,,,,,,1,1,admitted to a polyclinic or hospital with diarrhoea and if a faecal sample obtained during the admission yielded V cholerae O1.,,,,Hue residents at least 1 years old. Controls were same age enumerated in the census and residing in an odd-numbered household.,3,,,,64,5,86,,,,,,7,7185,19,7038,,1,2,2,100%,,,1,100%,,,"Ministry of Health of Vietnam, the Swedish Agency for Research Cooperation with Developing Countries, the Global Program on Vaccines and Immunisation of the WHO, and the USA National Institute of Child Health and Human Development.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1257,"Trach et al, 1997",1,VNM,5,WC,14,,1992-12-01,1993-01-01,1993-08-20,1993-10-04,58943,117745,58802,5.1,Inf,,,,,,,1,1,admitted to a polyclinic or hospital with diarrhoea and if a faecal sample obtained during the admission yielded V cholerae O1.,,,,Hue residents at least 1 years old. Controls were same age enumerated in the census and residing in an odd-numbered household.,3,,,,59,36,74,,,,,,30,58913,73,58729,,1,2,2,100%,,,1,100%,,,"Ministry of Health of Vietnam, the Swedish Agency for Research Cooperation with Developing Countries, the Global Program on Vaccines and Immunisation of the WHO, and the USA National Institute of Child Health and Human Development.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1257,"Trach et al, 1997",1,VNM,5,WC,14,,1992-12-01,1993-01-01,1993-08-20,1993-10-04,5901,12958,7057,1,5,,,,,,,1,1,admitted to a polyclinic or hospital with diarrhoea and if a faecal sample obtained during the admission yielded V cholerae O1.,,,,Hue residents at least 1 years old. Controls were same age enumerated in the census and residing in an odd-numbered household.,3,,,,69,15,88,,68,14,88,,5,5896,19,7038,,2,2,2,100%,,,1,100%,,,"Ministry of Health of Vietnam, the Swedish Agency for Research Cooperation with Developing Countries, the Global Program on Vaccines and Immunisation of the WHO, and the USA National Institute of Child Health and Human Development.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1257,"Trach et al, 1997",1,VNM,5,WC,14,,1992-12-01,1993-01-01,1993-08-20,1993-10-04,45364,104166,58802,5.1,Inf,,,,,,,1,1,admitted to a polyclinic or hospital with diarrhoea and if a faecal sample obtained during the admission yielded V cholerae O1.,,,,Hue residents at least 1 years old. Controls were same age enumerated in the census and residing in an odd-numbered household.,3,,,,64,41,79,,66,42,80,,20,45344,73,58729,,2,2,2,100%,,,1,100%,,,"Ministry of Health of Vietnam, the Swedish Agency for Research Cooperation with Developing Countries, the Global Program on Vaccines and Immunisation of the WHO, and the USA National Institute of Child Health and Human Development.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1257,"Trach et al, 1997",1,VNM,5,WC,14,,1992-12-01,1993-01-01,1993-08-20,1993-10-04,51975,119033,67058,1,Inf,,,,,,,1,1,"admitted to a polyclinic or hospital with diarrhoea and if a faecal sample obtained during the admission yielded V cholerae O1. Cholera was classified as severe if the doctor who examined the patient at presentation judged the patient to have moderate or severe dehydration,7 or if the patient died while in hospital or polyclinic.",1 or 2,,,Hue residents at least 1 years old. Controls were same age enumerated in the census and residing in an odd-numbered household.,3,,,,76,45,89,,76,46,89,,7,51968,37,67021,,2,2,2,100%,,,1,100%,,,"Ministry of Health of Vietnam, the Swedish Agency for Research Cooperation with Developing Countries, the Global Program on Vaccines and Immunisation of the WHO, and the USA National Institute of Child Health and Human Development.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1257,"Trach et al, 1997",1,VNM,5,WC,14,,1992-12-01,1993-01-01,1993-08-20,1993-10-04,51975,119033,67058,1,Inf,,,,,,,1,1,admitted to a polyclinic or hospital with diarrhoea and if a faecal sample obtained during the admission yielded V cholerae O1.,3,,,Hue residents at least 1 years old. Controls were same age enumerated in the census and residing in an odd-numbered household.,3,,,,57,25,75,,58,28,76,,18,51957,54,67004,,2,2,2,100%,,,1,100%,,,"Ministry of Health of Vietnam, the Swedish Agency for Research Cooperation with Developing Countries, the Global Program on Vaccines and Immunisation of the WHO, and the USA National Institute of Child Health and Human Development.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-31,3728,7558,3830,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,100,80,One tail,,,,,,0,3728,9,3821,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-03-26,16977,33984,17007,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,76,44,One tail,,,,,,4,16973,17,16990,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-31,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,21,-20,One tail,,,,,,26,-26,34,-34,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,"slightly less than the preepidemic counts, but data broken down by age is not available",,"slightly less than the preepidemic counts, but data broken down by age is not available",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-03-26,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,78,64,One tail,,,,,,11,-11,50,-50,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,"slightly less than the preepidemic counts, but data broken down by age is not available",,"slightly less than the preepidemic counts, but data broken down by age is not available",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-31,3728,7558,3830,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,38,7,One tail,,,,,,26,3702,43,3787,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-03-26,16977,33984,17007,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,78,66,One tail,,,,,,15,16962,67,16940,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,20705,41542,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,62,50,One tail,,,,,,41,20664,110,20727,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,3599,7273,3674,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,47,13,One tail,,,,,,16,3583,31,3643,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,16403,32741,16338,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,63,45,One tail,,,,,,25,16378,67,16271,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,20002,40014,20012,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,58,44,One tail,,,,,,41,19961,98,19914,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,3532,7132,3600,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-36,-126,One tail,,,,,,24,3508,18,3582,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,15838,31618,15780,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,41,10,One tail,,,,,,23,15815,39,15741,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,19370,38750,19380,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,18,-14,One tail,,,,,,47,19323,57,19323,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,3447,7004,3557,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-44,-276,One tail,,,,,,7,3440,5,3552,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,1460 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,15356,30704,15348,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,38,-28,One tail,,,,,,8,15348,13,15335,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,1460 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,18803,37708,18905,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,16,-49,One tail,,,,,,15,18788,18,18887,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,1460 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,14306,28967,14661,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,23,1,One tail,,,,,,73,14233,97,14564,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,1825 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,64574,129047,64473,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,62,52,One tail,,,,,,71,64503,186,64287,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,1825 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,78880,158014,79134,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,49,38,One tail,,,,,,144,78736,283,78851,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,1825 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-31,3900,7730,3830,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,35,-55,One tail,,,,,,6,3894,9,3821,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-03-26,16843,33850,17007,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,71,37,One tail,,,,,,5,16838,17,16990,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-31,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,31,-7,One tail,,,,,,24,-24,34,-34,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,"slightly less than the preepidemic counts, but data broken down by age is not available",,"slightly less than the preepidemic counts, but data broken down by age is not available",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-03-26,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,66,47,One tail,,,,,,17,-17,50,-50,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,"slightly less than the preepidemic counts, but data broken down by age is not available",,"slightly less than the preepidemic counts, but data broken down by age is not available",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,3900,7730,3830,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,31,-1,One tail,,,,,,30,3870,43,3787,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,16843,33850,17007,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,67,51,One tail,,,,,,22,16821,67,16940,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,20743,41580,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,53,38,One tail,,,,,,52,20691,110,20727,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,3745,7419,3674,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,24,-18,One tail,,,,,,24,3721,31,3643,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,16260,32598,16338,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,73,59,One tail,,,,,,18,16242,67,16271,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,20005,40017,20012,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,57,42,One tail,,,,,,42,19963,98,19914,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,3669,7269,3600,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,2,-70,One tail,,,,,,18,3651,18,3582,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,15755,31535,15780,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,61,38,One tail,,,,,,15,15740,39,15741,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,19424,38804,19380,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,42,18,One tail,,,,,,33,19391,57,19323,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,3600,7157,3557,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-19,-220,One tail,,,,,,6,3594,5,3552,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,1460 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,15305,30653,15348,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-31,-140,One tail,,,,,,17,15288,13,15335,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,18905,37810,18905,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-28,-114,One tail,,,,,,23,18882,18,18887,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,1460 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,14914,29575,14661,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,21,-1,One tail,,,,,,78,14836,97,14564,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,1825 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,64163,128636,64473,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,61,52,One tail,,,,,,72,64091,186,64287,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,1825 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,79077,158211,79134,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,47,36,One tail,,,,,,150,78927,283,78851,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-31,7628,11458,3830,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,67,24,One tail,,,,,,6,7622,9,3821,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-03-26,33820,50827,17007,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,73,50,One tail,,,,,,9,33811,17,16990,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,"slightly less than the preepidemic counts, but data broken down by age is not available",,"slightly less than the preepidemic counts, but data broken down by age is not available",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-04-09,1985-09-31,,,,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,26,-6,One tail,,,,,,50,-50,34,-34,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,See Clemens 1988 for how pre-epidemic and epidemic are defined,See Clemens 1988 for how pre-epidemic and epidemic are defined,"slightly less than the preepidemic counts, but data broken down by age is not available",,"slightly less than the preepidemic counts, but data broken down by age is not available",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-10-01,1986-03-26,,,,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,72,60,One tail,,,,,,28,-28,50,-50,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,7628,11458,3830,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,35,9,One tail,,,,,,56,7572,43,3787,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,33820,50827,17007,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,72,62,One tail,,,,,,37,33783,67,16940,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-04-09,1986-03-26,41448,62285,20837,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,57,47,One tail,,,,,,93,41355,110,20727,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,365 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,7344,11018,3674,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,35,5,One tail,,,,,,40,7304,31,3643,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,32663,49001,16338,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,67,56,One tail,,,,,,43,32620,67,16271,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1986-03-27,1987-03-26,40007,60019,20012,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,58,46,One tail,,,,,,83,39924,98,19914,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,366 days after 3rd dose,730 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,7201,10801,3600,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-17,-85,One tail,,,,,,42,7159,18,3582,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,31593,47373,15780,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,51,30,One tail,,,,,,38,31555,39,15741,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1987-03-27,1988-03-25,38794,58174,19380,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,30,7,One tail,,,,,,80,38714,57,19323,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,731 days after 3rd dose,1095 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,7047,10604,3557,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-31,-211,One tail,,,,,,13,7034,5,3552,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,1460 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,30661,46009,15348,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,4,-69,One tail,,,,,,25,30636,13,15335,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,1460 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1988-03-26,1989-03-25,37708,56613,18905,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,-6,-69,One tail,,,,,,38,37670,18,18887,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,1096 days after 3rd dose,1460 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,29220,43881,14661,2,5,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,22,3,One tail,,,,,,151,29069,97,14564,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,1825 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,128737,193210,64473,5.1,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,61,54,One tail,,,,,,143,128594,186,64287,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,1825 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
1287,"van Loon et al, 1996",1,BGD,5,BS-WC and WC,42,,1985-01-01,1985-05-31,1985-04-09,1990-03-25,157957,237091,79134,2,Inf,,,,,,,1,1,"""Cholera"" was defined as a diarrhoeal episode (WHO criteria) in which V cholerae 01 was isolated, the diarrhoea was described as non-bloody, and a field check confirmed the patient’s identity.",,,,2-15 years and females aged over 15 years residing in the vaccine trial area at the onset of vaccination,3,,,,48,39,One tail,,,,,,294,157663,283,78851,,3,3,,,,,,,,,"United States Agency for International Development, the Government of Japan, the Swedish Agency for Research Cooperation with Developing Countries, and the World Health Organisation.",,,,,"For this study ""vaccination proceeded in three six-week rounds, followed by a short one-week fourth round designed to give a third dose to two-dose recipients""",,,14 days after 3rd dose,1825 days after 3rd dose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"see table 2 for detail. Biotype of cases for each vaccine is not available, but biotype of cases is available by age-group and by years of followup",,Biotype specific VE available for each year of surveillance by age
96,"Wierzba et al, 2015",2,IND,1,,14,,2011-05-05,2011-06-25,2013-04-22,2014-03-31,7801,68,132,1,Inf,,,40.09,41,25-60,22.16,1,1,"Patients were study site residents who sought treatment at one of five health care facilities, met the definition of diarrhea, gave informed consent, were listed in the census database, submitted a fecal specimen, and found positive for V. cholerae infection. ",,,1,patients seeking treatment for V. cholerae negative diarrhea. Controls were only selected during the length of cholera season.,3,,1,,39.5,-215.7,88.4,,32.5,-318,89.1,,9,59,18,73,,1,1,2,100%,,,1,"No dose specific data, 34/44 were El Tor",3, 10/44 were hybrid (El Tor/Classical).,"Thrasher Research Fund, Utah, USA",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
96,"Wierzba et al, 2015",2,IND,1,,14,,2011-05-05,2011-06-25,2013-04-22,2014-03-31,23751,251,307,1,Inf,,,40.09,41,25-60,22.16,1,1,"Patients were study site residents who sought treatment at one of five health care facilities, met the definition of diarrhea, gave informed consent, were listed in the census database, submitted a fecal specimen, and found positive for V. cholerae infection. ",,,1,patients seeking treatment for V. cholerae negative diarrhea. Controls were only selected during the length of cholera season.,3,,1,,71.3,14.5,88.8,,69,14.5,88.8,,17,234,18,73,1,2,2,2,100%,,,1,"No dose specific data, 34/44 were El Tor",3, 10/44 were hybrid (El Tor/Classical).,"Thrasher Research Fund, Utah, USA",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,